Comparative efficacy and safety of olanzapine and risperidone in the treatment of psychiatric and behavioral symptoms of Alzheimer’s disease: Systematic review and meta-analysis
Article in Medicine (July 2024)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Tolerability and safety outcomes of first-line oral second-generation antipsychotics in patients with schizophrenia
Article in Expert Opinion on Drug Safety (March 2024)
Recovery-Oriented Psychopharmacological Interventions in Schizophrenia
Book chapter in Comprehensive Approach to Psychiatry (July 2022)